Q. Just really want to know, it was great and barely anyone remembers it.
Answer
Cheez-It is an American snack food cracker manufactured by the Kellogg Company through the Sunshine Biscuits division. They are roughly 26 by 24Â mm (1.0 by 0.95Â inch) rectangular crackers made with wheat flour, vegetable oil, sharp yellow cheese, salt, and spices. There are a variety of related Cheez-It products, including Baby Swiss, White Cheddar, Parmesan & Garlic, Cheddar Jack, Pepper Jack, Italian Four Cheese, Colby, Reduced Trans Fat, Snack Mix (formerly called Party Mix), Snack Mix Double Cheese, Hot & Spicy (made with Tabasco), Mozzarella, Duoz Sharp Cheddar & Parmesan, Duoz Smoked Cheddar & Monterey Jack, and the Cheez-It Big which is a larger cracker more suitable for garnishing or dipping.[1]
A Cheez-It cracker, shown near actual size on a 100Â ppi monitor
Cheez-It crackers
According to the United States Patent and Trademark Office trademark records, the first "Cheez-It" Cheese Crackers were sold by Green & Green Company of Dayton, Ohio, in May 1921. After the Wall Street Crash of 1929, The Green & Green Company was acquired by The Sunshine Biscuit Company, founded in 1902 as the Loose-Wiles Biscuit Company. The Keebler Company acquired Sunshine in 1996, and Keebler was in turn acquired by Kellogg in 2001. Cheez-It crackers are still sold under the Sunshine label.[2]
A former advertising slogan was "Get your own box" which was found on the backs of most boxes. One side also contained the so-called "Anatomy of a Cheez-It." In mid 2007, the boxes were changed to show a picture of a large wedge of cheese labeled "Actual Taste," while a Cheez-It is shown propping it up, labeled "Actual Size." The new slogan in place of "Get Your Own Box" is "Real cheese matters.", with Jim Cummings as the spokesperson in the television commercials.[3]
Cheez-It is an American snack food cracker manufactured by the Kellogg Company through the Sunshine Biscuits division. They are roughly 26 by 24Â mm (1.0 by 0.95Â inch) rectangular crackers made with wheat flour, vegetable oil, sharp yellow cheese, salt, and spices. There are a variety of related Cheez-It products, including Baby Swiss, White Cheddar, Parmesan & Garlic, Cheddar Jack, Pepper Jack, Italian Four Cheese, Colby, Reduced Trans Fat, Snack Mix (formerly called Party Mix), Snack Mix Double Cheese, Hot & Spicy (made with Tabasco), Mozzarella, Duoz Sharp Cheddar & Parmesan, Duoz Smoked Cheddar & Monterey Jack, and the Cheez-It Big which is a larger cracker more suitable for garnishing or dipping.[1]
A Cheez-It cracker, shown near actual size on a 100Â ppi monitor
Cheez-It crackers
According to the United States Patent and Trademark Office trademark records, the first "Cheez-It" Cheese Crackers were sold by Green & Green Company of Dayton, Ohio, in May 1921. After the Wall Street Crash of 1929, The Green & Green Company was acquired by The Sunshine Biscuit Company, founded in 1902 as the Loose-Wiles Biscuit Company. The Keebler Company acquired Sunshine in 1996, and Keebler was in turn acquired by Kellogg in 2001. Cheez-It crackers are still sold under the Sunshine label.[2]
A former advertising slogan was "Get your own box" which was found on the backs of most boxes. One side also contained the so-called "Anatomy of a Cheez-It." In mid 2007, the boxes were changed to show a picture of a large wedge of cheese labeled "Actual Taste," while a Cheez-It is shown propping it up, labeled "Actual Size." The new slogan in place of "Get Your Own Box" is "Real cheese matters.", with Jim Cummings as the spokesperson in the television commercials.[3]
What if Gardasil?
Q. Do you think Gardasil is a totally safe vaccine? What if in five years from now they find out that the people who have taken the vaccine won't be able to have babies or become pregnant? Should people be taking this risk, since it is a new vaccine? Do you think it is a safe vaccine?
Answer
side effects read and learn plz.
Gardasil
Side Effects & Drug Interactions
font size
A
A
A
SIDE EFFECTS
In 5 clinical trials (4 placebo-controlled), subjects were administered GARDASIL or placebo on the day of enrollment, and approximately 2 and 6 months thereafter. Few subjects (0.1%) discontinued due to adverse experiences. In all except 1 of the clinical trials, safety was evaluated using vaccination report card (VRC)-aided surveillance for 14 days after each injection of GARDASIL or placebo. The subjects who were monitored using VRC-aided surveillance included 5088 girls and women 9 through 26 years of age at enrollment who received GARDASIL and 3790 girls and women who received placebo.
Common Adverse Experiences
Vaccine-related Common Adverse Experiences
The vaccine-related adverse experiences that were observed among female recipients of GARDASIL at a frequency of at least 1.0% and also at a greater frequency than that observed among placebo recipients are shown in Table 6.
Table 6
Vaccine-related Injection-site and Systemic Adverse Experiences*
Adverse Experience
(1 to 5 Days Postvaccination)
GARDASIL
(N = 5088)
%
Aluminum-Containing
Placebo
(N = 3470)
%
Saline
Placebo
(N = 320)
%
Injection Site
Pain
83.9
75.4
48.6
Swelling
25.4
15.8
7.3
Erythema
24.6
18.4
12.1
Pruritus
3.1
2.8
0.6
Adverse Experience
(1 to 15 Days Postvaccination)
GARDASIL
(N = 5088)
%
Placebo
(N = 3790)
%
Systemic
Fever
10.3
8.6
*The vaccine-related adverse experiences that were observed among recipients of GARDASIL were at a frequency of at least 1.0% and also at a greater frequency than that observed among placebo recipients.
All-cause Common Systemic Adverse Experiences
All-cause systemic adverse experiences for female subjects that were observed at a frequency of greater than or equal to 1% where the incidence in the vaccine group was greater than or equal to the incidence in the placebo group are shown in Table 7.
Table 7
All-cause Common Systemic Adverse Experiences
Adverse Experience
(1 to 15 Days Postvaccination)
GARDASIL
(N = 5088)
%
Placebo
(N = 3790)
%
Pyrexia
13.0
11.2
Nausea
6.7
6.6
Nasopharyngitis
6.4
6.4
Dizziness
4.0
3.7
Diarrhea
3.6
3.5
Vomiting
2.4
1.9
Myalgia
2.0
2.0
Cough
2.0
1.5
Toothache
1.5
1.4
Upper respiratory tract infection
1.5
1.5
Malaise
1.4
1.2
Arthralgia
1.2
0.9
Insomnia
1.2
0.9
Nasal congestion
1.1
0.9
Evaluation of Injection-site Adverse Experiences by Dose
An analysis of injection-site adverse experiences in female subjects by dose is shown in Table 8. Overall, 94.3% of subjects who received GARDASIL judged their injection-site adverse experience to be mild or moderate in intensity.
the drug is new answer no...
it has to many side effects
best
side effects read and learn plz.
Gardasil
Side Effects & Drug Interactions
font size
A
A
A
SIDE EFFECTS
In 5 clinical trials (4 placebo-controlled), subjects were administered GARDASIL or placebo on the day of enrollment, and approximately 2 and 6 months thereafter. Few subjects (0.1%) discontinued due to adverse experiences. In all except 1 of the clinical trials, safety was evaluated using vaccination report card (VRC)-aided surveillance for 14 days after each injection of GARDASIL or placebo. The subjects who were monitored using VRC-aided surveillance included 5088 girls and women 9 through 26 years of age at enrollment who received GARDASIL and 3790 girls and women who received placebo.
Common Adverse Experiences
Vaccine-related Common Adverse Experiences
The vaccine-related adverse experiences that were observed among female recipients of GARDASIL at a frequency of at least 1.0% and also at a greater frequency than that observed among placebo recipients are shown in Table 6.
Table 6
Vaccine-related Injection-site and Systemic Adverse Experiences*
Adverse Experience
(1 to 5 Days Postvaccination)
GARDASIL
(N = 5088)
%
Aluminum-Containing
Placebo
(N = 3470)
%
Saline
Placebo
(N = 320)
%
Injection Site
Pain
83.9
75.4
48.6
Swelling
25.4
15.8
7.3
Erythema
24.6
18.4
12.1
Pruritus
3.1
2.8
0.6
Adverse Experience
(1 to 15 Days Postvaccination)
GARDASIL
(N = 5088)
%
Placebo
(N = 3790)
%
Systemic
Fever
10.3
8.6
*The vaccine-related adverse experiences that were observed among recipients of GARDASIL were at a frequency of at least 1.0% and also at a greater frequency than that observed among placebo recipients.
All-cause Common Systemic Adverse Experiences
All-cause systemic adverse experiences for female subjects that were observed at a frequency of greater than or equal to 1% where the incidence in the vaccine group was greater than or equal to the incidence in the placebo group are shown in Table 7.
Table 7
All-cause Common Systemic Adverse Experiences
Adverse Experience
(1 to 15 Days Postvaccination)
GARDASIL
(N = 5088)
%
Placebo
(N = 3790)
%
Pyrexia
13.0
11.2
Nausea
6.7
6.6
Nasopharyngitis
6.4
6.4
Dizziness
4.0
3.7
Diarrhea
3.6
3.5
Vomiting
2.4
1.9
Myalgia
2.0
2.0
Cough
2.0
1.5
Toothache
1.5
1.4
Upper respiratory tract infection
1.5
1.5
Malaise
1.4
1.2
Arthralgia
1.2
0.9
Insomnia
1.2
0.9
Nasal congestion
1.1
0.9
Evaluation of Injection-site Adverse Experiences by Dose
An analysis of injection-site adverse experiences in female subjects by dose is shown in Table 8. Overall, 94.3% of subjects who received GARDASIL judged their injection-site adverse experience to be mild or moderate in intensity.
the drug is new answer no...
it has to many side effects
best
Powered by Yahoo! Answers
Title Post: When and why did Cheez-Its let go of their saying, "Get Your Own Box"?
Rating: 96% based on 987 ratings. 4,3 user reviews.
Author: Unknown
Thanks For Coming To My Blog
Rating: 96% based on 987 ratings. 4,3 user reviews.
Author: Unknown
Thanks For Coming To My Blog
No comments:
Post a Comment